| 000 | 02570nam a2200313Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20251009160710.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-21941 | ||
| 245 | 1 | 0 | _aAnionic polysaccharides as delivery carriers for cancer therapy and theranostics: An overview of significance. |
| 490 | 0 | _aInternational Journal of Biological Macromolecules, 294, 139211, 2025. | |
| 500 | _aArtículo | ||
| 520 | 3 | _aRecently, cancer therapy has witnessed remarkable advancements with a growing focus on precision medicine and targeted drug delivery strategies. The application of anionic polysaccharides has gained traction in various drug delivery systems. Anionic polysaccharides have emerged as promising delivery carriers in cancer therapy and theranostics, offering numerous advantages such as biocompatibility, low toxicity, and the ability to encapsulate and deliver therapeutic agents to tumor sites with high specificity. This review underscores the significance of anionic polysaccharides as essential components of the evolving landscape of cancer therapy and theranostics. These polymers can be tailored to carry a wide range of therapeutic cargo, including chemotherapeutic agents, nucleic acids, and imaging agents. Their negative charge enables electrostatic interactions with positively charged drugs and facilitates the formation of stable nanoparticles, liposomes, or hydrogels for controlled drug release. Additionally, their hydrophilic nature aids in prolonging circulation time, reducing drug degradation, and minimizing off-target effects. Besides, some of them could act as targeting agents or therapeutic compounds that lead to improved therapeutic performance. This review offers valuable information for researchers, clinicians, and biomedical engineers. It provides insights into the recent progress in the applications of anionic polysaccharide-based delivery platforms in cancer theranostics to transform patient outcomes. | |
| 650 | 1 | 4 | _aANIONIC POLYSACCHARIDES |
| 650 | 1 | 4 | _aCANCER NANOMEDICINE |
| 650 | 1 | 4 | _aTHERANOSTICS |
| 650 | 1 | 4 | _aBIOPOLYMER |
| 650 | 1 | 4 | _aTARGETED DRUG DELIVERY |
| 700 | 1 | 2 | _aSivakumar, P. M. |
| 700 | 1 | 2 | _aZarepour, A. |
| 700 | 1 | 2 | _aAkhter, S. |
| 700 | 1 | 2 | _aPerumal, G. |
| 700 | 1 | 2 | _aKhosravi, A. |
| 700 | 1 | 2 | _aBalasekar, P. |
| 700 | 1 | 2 | _aZarrabi, A. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1WpyiVlUQQTtzBKQWf0Uu3ie2o4iMzQMc/view?usp=drive_link _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 251009s9999 xx 000 0 und d | ||
| 999 |
_c62030 _d62030 |
||